Protalix BioTherapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | $388.0K | $-32.0M | $-31.4M |
| FY2010 | $6.6M | $-30.0M | $-29.0M |
| FY2011 | $8.4M | $-36.5M | $-36.5M |
| FY2012 | $34.9M | $-12.2M | $-11.6M |
| FY2013 | $0 | $-34.1M | $-27.8M |
| FY2014 | $3.5M | $-28.6M | $-29.9M |
| FY2015 | $4.4M | $-23.7M | $58.0M |
| FY2016 | $9.2M | $-33.2M | $-29.4M |
| FY2017 | $21.1M | $-34.5M | $-83.4M |
| FY2018 | $34.2M | $-19.3M | $-26.5M |
| FY2019 | $54.7M | $-10.7M | $-18.3M |
| FY2020 | $62.9M | $2.7M | $-6.5M |
| FY2021 | $38.4M | $-20.5M | $-27.6M |
| FY2022 | $47.6M | $-13.0M | $-14.9M |
| FY2023 | $65.5M | $10.5M | $8.3M |
| FY2024 | $53.4M | $3.9M | $2.9M |
| FY2025 | $52.7M | $-5.5M | $-6.6M |